ACE and Nephropathy: Indeed, inhibition of RAS by angiotensin-converting enzyme (ACE) inhibitor or angiotensin II (Ang II) type-1 receptor (AT1R) blocker has been shown to suppress the development and progression of nephropathy in both type-1 and type-2 diabetic subjects [25, 26].